MetLife Investment Management’s XP XP Stock Holding History

MetLife Investment Management’s Portfolio XP Stock Details XP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$104K	Sell	6,407 -1,654	-21%	-$29.5K	﹤0.01%	2762
2026 Q1	$153K	Sell	8,061 -98	-1%	-$1.89K	﹤0.01%	2345
2025 Q4	$134K	Sell	8,159 -295	-3%	-$5.19K	﹤0.01%	2469
2025 Q3	$159K	Buy	8,454 +72	+0.9%	+$1.29K	﹤0.01%	2441
2025 Q2	$169K	Sell	8,382 -747	-8%	-$12.9K	﹤0.01%	2277
2025 Q1	$126K	Buy	9,129 +146	+2%	+$2.01K	﹤0.01%	2415
2024 Q4	$106K	Sell	8,983 -39	-0.4%	-$614	﹤0.01%	2590
2024 Q3	$162K	Sell	9,022 -196	-2%	-$3.57K	﹤0.01%	2396
2024 Q2	$162K	Buy	9,218 +1,812	+24%	+$37.4K	﹤0.01%	2370
2024 Q1	$190K	Buy	7,406 +19	+0.3%	+$476	﹤0.01%	2233
2023 Q4	$193K	Sell	7,387 -348	-4%	-$7.94K	﹤0.01%	2267
2023 Q3	$178K	Buy	7,735 +10	+0.1%	+$251	﹤0.01%	2278
2023 Q2	$181K	Buy	+7,725	New	+$131K	﹤0.01%	2338

Other funds holding XP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

AIM

ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

MetLife Investment Management's XP Position: Q2 2026 in Review

MetLife Investment Management reduced its XP (XP) stake by 21% in Q2 2026, selling an estimated $29.5K and leaving 6,407 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #2762.

MetLife Investment Management first reported a position in XP in Q2 2023 and has held it in 13 quarters since. The position peaked at $193K in Q4 2023. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

MetLife Investment Management held 6,407 shares of XP worth $104K as of Q2 2026.
MetLife Investment Management sold 1,654 XP shares in Q2 2026, an estimated $29.5K.
XP made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2762 holding.
MetLife Investment Management first reported a position in XP in Q2 2023 and has held it in 13 quarters since.
MetLife Investment Management's XP position peaked at $193K in Q4 2023.
320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.